CEO of Pandion Therapeutics Inc (30-Year Financial, Insider Trades) Rahul Kakkar (insider trades) bought 14,000 shares of PAND on 07/21/2020 at an average price of $18 a share. The total cost of this purchase was $252,000.
Pandion Therapeutics Inc has a market cap of $513.170 million; its shares were traded at around $17.99 .
CEO Recent Trades:
- CEO Rahul Kakkar bought 14,000 shares of PAND stock on 07/21/2020 at the average price of $18. The price of the stock has decreased by 0.06% since.
Directors and Officers Recent Trades:
- 10% Owner Entrepreneurs' Fund Vi Polaris bought 36,111 shares of PAND stock on 07/21/2020 at the average price of $18. The price of the stock has decreased by 0.06% since.
- 10% Owner Capital, Llc Boxer bought 722,222 shares of PAND stock on 07/21/2020 at the average price of $18. The price of the stock has decreased by 0.06% since.
- Director, 10% Owner Jill Carroll bought 361,111 shares of PAND stock on 07/21/2020 at the average price of $18. The price of the stock has decreased by 0.06% since.
- Director, 10% Owner Alan L Crane bought 50,111 shares of PAND stock on 07/21/2020 at the average price of $18. The price of the stock has decreased by 0.06% since.
- Director, 10% Owner Christopher Fuglesang bought 722,222 shares of PAND stock on 07/21/2020 at the average price of $18. The price of the stock has decreased by 0.06% since.
For the complete insider trading history of PAND, click here
.
